Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Groot

Showing results (501-510 of 568) with videos related to

Pageof 57
Sort By:
The International Journal of Cardiovascular Imaging|November 29, 2022
Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT studySarah W E Baalman, Nicoline W E van den Berg, Jolien Neefs, et al.
Circulation|March 26, 2014
Permanent leadless cardiac pacing: results of the LEADLESS trialVivek Y Reddy, Reinoud E Knops, Johannes Sperzel, et al.
Blood Advances|October 11, 2022
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control studyCarin L E Hazenberg, Aniek O de Graaf, René Mulder, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 29, 2023
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial FibrillationSabine F B van der Horst, Tim A C de Vries, Gordon Chu, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Frontiers in Immunology|May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell TransplantationsKirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Pageof 57

Showing results (501-510 of 568) with videos related to

Sort By:
Pageof 57
The International Journal of Cardiovascular Imaging|November 29, 2022
Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT studySarah W E Baalman, Nicoline W E van den Berg, Jolien Neefs, et al.
Circulation|March 26, 2014
Permanent leadless cardiac pacing: results of the LEADLESS trialVivek Y Reddy, Reinoud E Knops, Johannes Sperzel, et al.
Blood Advances|October 11, 2022
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control studyCarin L E Hazenberg, Aniek O de Graaf, René Mulder, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 29, 2023
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial FibrillationSabine F B van der Horst, Tim A C de Vries, Gordon Chu, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Frontiers in Immunology|May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell TransplantationsKirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Pageof 57